Ann: Pause in Trading, page-24

kates

Thanks for that.  It looks like all abstracts are embargoed.  Why IMU even bothered to mention the embargo, who knows.  If it was an attempt to drum up interest then it was a bit of a cheap shot.  Given that precious little was given away, why run the announcement as price sensitive? 

From what you've posted, it looks like the start of the conference will let us know whether the IMU presentation is a bit special. . . 

• The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 3:00 p.m. U.S. ET on Friday, March 29, 2019, except those abstracts that are selected for inclusion in the AACR press program.
• Abstracts that are featured in the AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.

If the Imugene abstract doesn't show up online when the bulk of them do at the start of the conference, then it's been selected for the AACR press program and contains something the AACR found worthy of making a noise about.

Cheers